Oppenheimer Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,306
| Closed | -$209K | – | 1201 |
|
|
2024
Q3 | $209K | Sell |
5,306
-74
| -1% | -$2.91K | ﹤0.01% | 1091 |
|
|
2024
Q2 | $210K | Buy |
5,380
+6
| +0.1% | +$234 | ﹤0.01% | 1071 |
|
|
2024
Q1 | $231K | Buy |
5,374
+946
| +21% | +$40.7K | ﹤0.01% | 1017 |
|
|
2023
Q4 | $204K | Sell |
4,428
-1,783
| -29% | -$82.1K | ﹤0.01% | 1083 |
|
|
2023
Q3 | $212K | Sell |
6,211
-19
| -0.3% | -$649 | ﹤0.01% | 1041 |
|
|
2023
Q2 | $240K | Buy |
+6,230
| New | +$240K | ﹤0.01% | 1022 |
|